Analyst firm TD Cowen issued buy ratings for Molecular Partners, a company based in Switzerland.
2 reports, 1 independent
Updated Jul 1
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst firm TD Cowen issued buy ratings for Molecular Partners, a company based in Switzerland.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
Molecular Partners
biopharmaceutical company based in Zürich, Switzerland
Nothing else this week.
-
Switzerland
country in Central Europe
Related events
- TD Cowen boosted its price target and gave a buy rating for Jazz Pharmaceuticals.
- TD Cowen reiterated its buy rating on ExlService Holdings, Inc. shares.
- TD Cowen, Bank of America, and Royal Bank of Canada issued new ratings and coverage notes on November 5, 2026.
- TD Cowen and Bank of America issued buy ratings and increased price targets on November 2, 2026.
- TD Cowen and Scotiabank provided ratings and price targets for Devon Energy.